Echo Therapeutics' Unattributed VC - II Round

Echo Therapeutics raised a round of funding on February 15, 2002. Investors include Vanguard Ventures.

Echo Therapeutics is focused on medical devices and specialty pharmaceuticals. Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system…

Articles about Echo Therapeutics' Unattributed VC - II Round: